Hypervariable Region 1 in Envelope Protein 2 of Hepatitis C Virus: A Linchpin in Neutralizing Antibody Evasion and Viral Entry

by Jannick Prentoe, Jannick Prentoe, Jens Bukh, Jens Bukh
Published 2018-09-01

Lipid Droplets Accumulation during Hepatitis C Virus Infection in Cell-Culture Varies among Genotype 1–3 Strains and Does Not Correlate with Virus Replication

by Andrea Galli, Santseharay Ramirez, Jens Bukh
Published 2021-02-01

Applying antibody-sensitive hypervariable region 1-deleted hepatitis C virus to the study of escape pathways of neutralizing human monoclonal antibody AR5A.

by Rodrigo Velázquez-Moctezuma, Mansun Law, Jens Bukh, Jannick Prentoe
Published 2017-02-01

In vitro adaptation and characterization of attenuated hypervariable region 1 swap chimeras of hepatitis C virus.

by Christina Holmboe Olesen, Elias H Augestad, Fulvia Troise, Jens Bukh, Jannick Prentoe
Published 2021-07-01

The Role of CTLA-4 in T Cell Exhaustion in Chronic Hepatitis B Virus Infection

by Ása Didriksen Apol, Anni Assing Winckelmann, Rasmus Bülow Duus, Jens Bukh, Nina Weis
Published 2023-05-01

Productive homologous and non-homologous recombination of hepatitis C virus in cell culture.

by Troels K H Scheel, Andrea Galli, Yi-Ping Li, Lotte S Mikkelsen, Judith M Gottwein, Jens Bukh
Published 2013-03-01

Analysis of functional differences between hepatitis C virus NS5A of genotypes 1-7 in infectious cell culture systems.

by Troels K H Scheel, Jannick Prentoe, Thomas H R Carlsen, Lotte S Mikkelsen, Judith M Gottwein, Jens Bukh
Published 2012-01-01

Efficacy of Ion-Channel Inhibitors Amantadine, Memantine and Rimantadine for the Treatment of SARS-CoV-2 In Vitro

by Yuyong Zhou, Karen A. Gammeltoft, Andrea Galli, Anna Offersgaard, Ulrik Fahnøe, Santseharay Ramirez, Jens Bukh, Judith M. Gottwein
Published 2021-10-01

SARS-CoV-2 spike HexaPro formulated in aluminium hydroxide and administered in an accelerated vaccination schedule partially protects Syrian Hamsters against viral challenge despit...

by Dennis Christensen, Charlotta Polacek, Daniel J. Sheward, Leo Hanke, Gerald McInerney, Ben Murrell, Katrine Top Hartmann, Henrik Elvang Jensen, Julie Zimmermann, Gregers Jungersen, Kristin Engelhart Illigen, Louise Krag Isling, Carlota Fernandez-Antunez, Carlota Fernandez-Antunez, Santseharay Ramirez, Santseharay Ramirez, Jens Bukh, Jens Bukh, Gabriel Kristian Pedersen
Published 2023-01-01

Novel HCV Genotype 4d Infectious Systems and Assessment of Direct-Acting Antivirals and Antibody Neutralization

by Long V. Pham, Rodrigo Velázquez-Moctezuma, Ulrik Fahnøe, Laura Collignon, Priyanka Bajpai, Christina Sølund, Nina Weis, Kenn Holmbeck, Jannick Prentoe, Jens Bukh
Published 2022-11-01

Neutralizing antibodies in patients with chronic hepatitis C, genotype 1, against a panel of genotype 1 culture viruses: lack of correlation to treatment outcome.

by Jannie Pedersen, Tanja B Jensen, Thomas H R Carlsen, Kristian Schønning, Peer Brehm Christensen, Alex Lund Laursen, Henrik Krarup, Jens Bukh, Nina Weis
Published 2013-01-01

Characterising the RNA-binding protein atlas of the mammalian brain uncovers RBM5 misregulation in mouse models of Huntington’s disease

by Meeli Mullari, Nicolas Fossat, Niels H. Skotte, Andrea Asenjo-Martinez, David T. Humphreys, Jens Bukh, Agnete Kirkeby, Troels K. H. Scheel, Michael L. Nielsen
Published 2023-07-01

Virus Adaptation and Selection Following Challenge of Animals Vaccinated against Classical Swine Fever Virus

by Ulrik Fahnøe, Anders Gorm Pedersen, Camille Melissa Johnston, Richard J. Orton, Dirk Höper, Martin Beer, Jens Bukh, Graham J. Belsham, Thomas Bruun Rasmussen
Published 2019-10-01

Identification of the viral and cellular microRNA interactomes during SARS-CoV-2 infection

by Nicolas Fossat, Emma A. Lundsgaard, Rui Costa, Lizandro R. Rivera-Rangel, Louise Nielsen, Lotte S. Mikkelsen, Santseharay Ramirez, Jens Bukh, Troels K.H. Scheel
Published 2023-04-01

Hepatitis C virus cell-cell transmission and resistance to direct-acting antiviral agents.

by Fei Xiao, Isabel Fofana, Laura Heydmann, Heidi Barth, Eric Soulier, François Habersetzer, Michel Doffoël, Jens Bukh, Arvind H Patel, Mirjam B Zeisel, Thomas F Baumert
Published 2014-05-01

High-Titer Hepatitis C Virus Production in a Scalable Single-Use High Cell Density Bioreactor

by Anna Offersgaard, Carlos Rene Duarte Hernandez, Anne Finne Pihl, Nandini Prabhakar Venkatesan, Henrik Krarup, Xiangliang Lin, Udo Reichl, Jens Bukh, Yvonne Genzel, Judith Margarete Gottwein
Published 2022-02-01

In vitro Characterization of Fitness and Convalescent Antibody Neutralization of SARS-CoV-2 Cluster 5 Variant Emerging in Mink at Danish Farms

by Ria Lassaunière, Jannik Fonager, Morten Rasmussen, Anders Frische, Charlotta Polacek, Thomas Bruun Rasmussen, Louise Lohse, Graham J. Belsham, Alexander Underwood, Alexander Underwood, Anni Assing Winckelmann, Anni Assing Winckelmann, Signe Bollerup, Jens Bukh, Jens Bukh, Nina Weis, Nina Weis, Susanne Gjørup Sækmose, Bitten Aagaard, Alonzo Alfaro-Núñez, Kåre Mølbak, Kåre Mølbak, Anette Bøtner, Anette Bøtner, Anders Fomsgaard
Published 2021-06-01

Neutralizing antibody and CD8+ T cell responses following BA.4/5 bivalent COVID-19 booster vaccination in adults with and without prior exposure to SARS-CoV-2

by Alexander P. Underwood, Alexander P. Underwood, Christina Sølund, Christina Sølund, Kivin Jacobsen, Alekxander Binderup, Alekxander Binderup, Carlota Fernandez-Antunez, Carlota Fernandez-Antunez, Lotte S. Mikkelsen, Lotte S. Mikkelsen, Dilek Inekci, Signe Lysemose Villadsen, Signe Lysemose Villadsen, Jose A. S. Castruita, Mette Pinholt, Ulrik Fahnøe, Ulrik Fahnøe, Santseharay Ramirez, Santseharay Ramirez, Liselotte Brix, Nina Weis, Nina Weis, Jens Bukh, Jens Bukh
Published 2024-03-01

Identification of Novel Determinants of Neutralization Epitope Shielding for Hepatitis C Virus in Vitro

by Garazi Peña Alzua, Anne Finne Pihl, Anna Falden Offersgaard, Rodrigo Velázquez-Moctezuma, Elias Honeroed Augestad, Ulrik Fahnøe, Christian Kjaerulff Mathiesen, Mansun Law, Jannick Prentoe, Jens Bukh, Judith Margarete Gottwein
Published 2020-06-01

Two-component vaccine consisting of virus-like particles displaying hepatitis C virus envelope protein 2 oligomers

by Jannick Prentoe, Christoph M. Janitzek, Rodrigo Velázquez-Moctezuma, Andreas Soerensen, Thomas Jørgensen, Stine Clemmensen, Vladislav Soroka, Susan Thrane, Thor Theander, Morten A. Nielsen, Ali Salanti, Jens Bukh, Adam F. Sander
Published 2022-11-01